The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
A bipartisan group of state health policymakers from both the executive and legislative branches who are focused on improving population health.
Networks of state officials, advocates, and others aiming to invest in and transform primary care.
A program dedicated to advancing state-based efforts to make health care more affordable for residents, employers, and states.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
A leadership development program for early and mid-career state government officials who are committed to improving the health of all people in their communities.
A leadership program for senior state government officials who are committed to improving population health.
The Fund focuses on creating an affordable health care system built on strong primary care and partnerships that improve health outcomes for all.
Improving state leaders’ ability to enact and implement evidence-based health policies.
Advancing policies that create a more prevention- and primary care-oriented health system.
Improving population health through policies that contain health care cost growth.
Our state health policy resources offer relevant data analysis and best practices.
The Fund publishes reports, issues briefs, and case studies on state health policy issues.
Short takes on health policy issues from Milbank staff and guest authors.
Insights from Milbank President Debra Lubar on state health policymaking.
Reported articles and Q&As on timely health policy issues, as well as foundation updates.
Milbank Memorial Fund and Milbank Quarterly webinars featuring state health policymakers and researchers.
Updates and expert contact information for reporters.
The Milbank Memorial Fund is a private foundation that works to improve population health and health equity.
March 2024 (Volume 102)
Quarterly Article
Eduardo J. Gómez
Nason Maani
Sandro Galea
June 2026
March 2026
September 2025
Back to The Milbank Quarterly
Policy Points:
The rise of noncommunicable diseases (NCDs) is a manifestation of a global economic system that currently prioritizes wealth creation over health creation. Many key problems and solutions lie outside the health sector. It is well established that commercial actors contribute to poor health through, for example, the production and marketing of harmful products such as calorie-dense, nutrient-poor foods. Some also believe that industries have been predatory in nature (i.e., marketing their products to vulnerable populations, such as children and the poor).1, 2 Commercial actors, through their industry representatives, have also been perceived as indirectly contributing to our poor health by seeking to shape the science (e.g., cherry-picking and revealing data that question the relationship between sugar consumption and ill health) used to question the need for soda taxes3; the regulatory environments, such as lobbying against marketing restrictions or soda taxes or working with the government to cosponsor health campaigns and/or engage in product self-regulation in turn generate government incentives and precedents not to pursue regulations.4–6 Commercial actors have also defended social norms, “weaponizing” issues such as defending individual liberties in the right to consume whichever products individuals desire in order to avoid regulations—deemed as “nanny state” intrusions—and to maximize future revenue.7